Innovent Biologics Eigentümerschaft
Wer sind die Hauptanteilseigner und gab es Insider-Transaktionen?
Jüngste Insider-Transaktionen
Datum | Wert | Name | Entität | Rolle | Aktien | Maximaler Preis |
---|---|---|---|---|---|---|
30 Oct 24 | SellUS$39,665,163 | JPMorgan Chase & Co, Brokerage and Securities Investments | Company | 8,668,935 | US$4.58 | |
29 Oct 24 | BuyUS$22,367,077 | JPMorgan Chase & Co, Brokerage and Securities Investments | Company | 4,592,813 | US$4.87 | |
10 Oct 24 | SellUS$68,722,897 | JPMorgan Chase & Co, Brokerage and Securities Investments | Company | 10,891,140 | US$6.31 | |
08 Oct 24 | BuyUS$70,495,950 | JPMorgan Chase & Co, Brokerage and Securities Investments | Company | 11,412,177 | US$6.18 | |
02 Oct 24 | SellUS$10,454,736 | De-Chao Yu | Individual | 1,750,000 | US$6.02 | |
30 Sep 24 | SellUS$9,084,814 | De-Chao Yu | Individual | 1,500,000 | US$6.10 | |
27 Sep 24 | SellUS$4,330,187 | Hao Xi Ede | Individual | 736,500 | US$5.88 | |
26 Sep 24 | SellUS$469,386 | Hao Xi Ede | Individual | 81,500 | US$5.76 | |
11 Sep 24 | BuyUS$11,040 | JPMorgan Chase & Co, Brokerage and Securities Investments | Company | 2,000 | US$5.52 | |
11 Sep 24 | BuyUS$11,040 | JPMorgan Chase & Co, Private Banking and Investment Banking Investments | Company | 2,000 | US$5.52 | |
11 Sep 24 | SellUS$223,559 | JP Morgan Asset Management | Company | 40,500 | US$5.52 | |
11 Sep 24 | SellUS$85,461,245 | JPMorgan Chase & Co, Brokerage and Securities Investments | Company | 15,482,177 | US$5.52 | |
10 Sep 24 | BuyUS$57,544,602 | JPMorgan Chase & Co, Brokerage and Securities Investments | Company | 10,624,087 | US$5.42 | |
10 Jul 24 | SellUS$12,728,577 | Capital Research and Management Company | Company | 2,755,000 | US$4.62 | |
03 May 24 | SellUS$4,683,731 | De-Chao Yu | Individual | 906,250 | US$5.17 | |
02 Feb 24 | BuyUS$7,773,313 | Capital Research and Management Company | Company | 1,869,776 | US$4.16 | |
12 Jan 24 | BuyUS$6,636,262 | Capital Research and Management Company | Company | 1,292,500 | US$5.13 | |
05 Jan 24 | SellUS$17,121,093 | Capital Research and Management Company | Company | 3,456,000 | US$4.95 |
Volumen des Insiderhandels
Insider-Käufe: IVBX.F Die Insider haben nur in den letzten 3 Monaten Aktien verkauft.
Aufschlüsselung der Eigentumsverhältnisse
Typ des Eigentümers | Anzahl der Aktien | Eigentumsanteil in Prozent |
---|---|---|
Private Unternehmen | 10.614.500 | 0,648 % |
VC/PE-Firmen | 89.475.350 | 5,46 % |
Einzelne Insider | 110.666.823 | 6,76 % |
Allgemeine Öffentlichkeit | 672.781.363 | 41,1 % |
Einrichtungen | 754.371.810 | 46,1 % |
Verwässerung von Anteilen: Die Aktionäre wurden im vergangenen Jahr nicht nennenswert verwässert.
Top-Aktionäre
Eigentümerschaft | Name | Aktien | Aktueller Wert | Veränderung in % | Portfolio % | |
---|---|---|---|---|---|---|
113.425.003 | US$539.1m | -0,65 % | 0,03 % | |||
107.003.778 | US$508.6m | -1,61 % | keine Daten | |||
89.475.350 | US$425.3m | 0 % | 25,03 % | |||
58.303.814 | US$277.1m | -0,24 % | keine Daten | |||
55.364.540 | US$263.2m | 0 % | 46,9 % | |||
43.213.751 | US$205.4m | 1,59 % | keine Daten | |||
36.440.000 | US$173.2m | 0 % | 0,36 % | |||
32.441.094 | US$154.2m | 0 % | 0,01 % | |||
30.155.835 | US$143.3m | 0,09 % | 0,06 % | |||
29.751.000 | US$141.4m | 136 % | 0,12 % | |||
24.932.063 | US$118.5m | 0 % | 0,09 % | |||
23.965.000 | US$113.9m | 0 % | 0,5 % | |||
23.397.288 | US$111.2m | 0 % | 0,24 % | |||
18.603.000 | US$88.4m | 0 % | 0,1 % | |||
14.276.500 | US$67.9m | 0 % | 75,69 % | |||
13.674.179 | US$65.0m | 93,8 % | 0,03 % | |||
13.574.174 | US$64.5m | -11,7 % | keine Daten | |||
11.944.751 | US$56.8m | -0,96 % | 0,06 % | |||
10.295.500 | US$48.9m | 0 % | 0,03 % | |||
9.652.500 | US$45.9m | 5,61 % | 0,14 % | |||
8.812.894 | US$41.9m | 3,06 % | 0,16 % | |||
8.343.974 | US$39.7m | 0 % | 0,21 % | |||
7.802.000 | US$37.1m | 1,36 % | 0,01 % | |||
7.345.000 | US$34.9m | 0 % | 29,86 % | |||
6.673.500 | US$31.7m | 0 % | keine Daten |